EXBIO

EXBIO entered the antibody market as a spin-off company of the Czech Academy of Sciences in 1990. Now widely recognized as a leading manufacturer of high-quality antibodies and reagents for research and clinical applications, the company has a strong focus on multi-color flow cytometric analysis of human cellular markers.

EXBIO antibodies have proven utility in detecting CD and related antigens, blood group antigens, MHC antigens, cytoskeleton proteins, intracellular antigens, and many other targets. Both monoclonal antibodies and polyclonal antibodies are available within a comprehensive, ISO-accredited portfolio, along with a wide range of supporting products to accelerate scientific research.